THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q2 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $14,000 | +7.7% | 37,544 | 0.0% | 0.01% | +16.7% |
Q4 2021 | $13,000 | -53.6% | 37,544 | 0.0% | 0.01% | -57.1% |
Q3 2021 | $28,000 | -37.8% | 37,544 | 0.0% | 0.01% | -36.4% |
Q2 2021 | $45,000 | -10.0% | 37,544 | 0.0% | 0.02% | -15.4% |
Q1 2021 | $50,000 | +11.1% | 37,544 | 0.0% | 0.03% | 0.0% |
Q4 2020 | $45,000 | -23.7% | 37,544 | 0.0% | 0.03% | -33.3% |
Q3 2020 | $59,000 | +84.4% | 37,544 | +48.3% | 0.04% | +200.0% |
Q2 2020 | $32,000 | +18.5% | 25,324 | 0.0% | 0.01% | +8.3% |
Q1 2020 | $27,000 | -55.7% | 25,324 | 0.0% | 0.01% | -42.9% |
Q4 2019 | $61,000 | -33.7% | 25,324 | 0.0% | 0.02% | -38.2% |
Q3 2019 | $92,000 | +39.4% | 25,324 | 0.0% | 0.03% | +47.8% |
Q2 2019 | $66,000 | -46.3% | 25,324 | 0.0% | 0.02% | -36.1% |
Q1 2019 | $123,000 | +28.1% | 25,324 | 0.0% | 0.04% | +20.0% |
Q4 2018 | $96,000 | -42.2% | 25,324 | 0.0% | 0.03% | -14.3% |
Q3 2018 | $166,000 | +5.1% | 25,324 | 0.0% | 0.04% | +16.7% |
Q2 2018 | $158,000 | -70.1% | 25,324 | -76.6% | 0.03% | -65.9% |
Q1 2018 | $528,000 | -40.0% | 108,363 | -25.6% | 0.09% | -37.6% |
Q4 2017 | $880,000 | +14.1% | 145,692 | 0.0% | 0.14% | +16.5% |
Q3 2017 | $771,000 | -25.3% | 145,692 | -25.6% | 0.12% | -21.4% |
Q2 2017 | $1,032,000 | -69.3% | 195,743 | -58.1% | 0.15% | -66.1% |
Q1 2017 | $3,365,000 | +13.2% | 467,425 | -9.3% | 0.45% | +12.4% |
Q4 2016 | $2,972,000 | -4.5% | 515,111 | +12.8% | 0.40% | -10.4% |
Q3 2016 | $3,111,000 | -21.6% | 456,817 | -2.2% | 0.45% | -23.8% |
Q2 2016 | $3,969,000 | +32.2% | 466,917 | -0.4% | 0.59% | +34.5% |
Q1 2016 | $3,002,000 | -41.5% | 468,986 | -5.3% | 0.44% | -36.3% |
Q4 2015 | $5,135,000 | +71.9% | 495,190 | -2.9% | 0.69% | +64.9% |
Q3 2015 | $2,988,000 | -1.2% | 509,872 | +32.6% | 0.42% | +12.3% |
Q2 2015 | $3,023,000 | -8.5% | 384,571 | -29.6% | 0.37% | -3.9% |
Q1 2015 | $3,304,000 | +37.0% | 546,057 | +0.7% | 0.39% | +22.0% |
Q4 2014 | $2,412,000 | +14.7% | 542,053 | +19.6% | 0.32% | +1.9% |
Q3 2014 | $2,103,000 | +12.6% | 453,218 | +7.2% | 0.31% | +11.4% |
Q2 2014 | $1,868,000 | +165.3% | 422,681 | +212.6% | 0.28% | +107.4% |
Q4 2013 | $704,000 | – | 135,208 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |